IMPACT OF INCREASING CALCIUM IN THE DIET ON NUTRIENT CONSUMPTION, PLASMA-LIPIDS, AND LIPOPROTEINS IN HUMANS

被引:43
|
作者
KARANJA, N
MORRIS, CD
RUFOLO, P
SNYDER, G
ILLINGWORTH, DR
MCCARRON, DA
机构
[1] Div. of Nephrology and Hypertension, Department of Medicine, Oregon Health Sciences University, Portland, OR
[2] Department of Medicine, Div. of Nephrology and Hypertension, Oregon Health Sciences University, Portland, OR 97201
来源
关键词
DIETARY CALCIUM; CALCIUM CARBONATE; HYPERTENSION; PLASMA LIPIDS; PLASMA LIPOPROTEINS; NUTRIENT MULTICOLLINEARITY;
D O I
10.1093/ajcn/59.4.900
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This study examined the feasibility of increasing food-derived calcium to 1500 mg/d and the impact of this change on plasma lipids and nutrient consumption in hypertensive (n = 130) and normotensive (n = 196) participants. Three interventions were applied in a randomized, parallel, placebo-controlled fashion: 1) counseling to increase dietary calcium through food consumption to 1500 mg/d (n = 106), 2) a 1000-mg/d calcium supplement (n = 109), or 3) placebo (n = 111). Plasma lipids were measured before and after 12 wk of intervention whereas nutrient intake was monitored throughout the study. At baseline, hypertensive patients reported lower intakes of carbohydrates, calcium, magnesium, phosphorus, potassium, iron, vitamin D, thiamin, and riboflavin (all P < 0.05). They also had lower HDL (P = 0.014) and higher LDL (P < 0.05) compared with normotensive subjects. During intervention, calcium, magnesium, phosphorus, potassium, thiamin, riboflavin, and vitamins C and D increased (P < 0.01) in the group receiving food calcium but not in the placebo or supplement groups. No changes occurred in plasma lipids or lipoproteins after 12 wk of intervention.
引用
下载
收藏
页码:900 / 907
页数:8
相关论文
共 50 条
  • [31] PLASMA-LIPIDS AND LIPOPROTEINS IN DOWNS-SYNDROME
    SALO, MK
    SOLAKIVIJAAKKOLA, T
    KIVIMAKI, T
    NIKKARI, T
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1979, 39 (05): : 485 - 490
  • [32] PLASMA-LIPIDS, LIPOPROTEINS AND CELL-MEMBRANES
    OWEN, JS
    GILLETT, MPT
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1983, 11 (04) : 336 - 339
  • [33] PHYSICAL-ACTIVITY AND PLASMA-LIPIDS AND LIPOPROTEINS
    HUTTUNEN, JK
    ANNALS OF CLINICAL RESEARCH, 1982, 14 : 124 - 129
  • [34] CHARACTERIZATION OF THE PLASMA-LIPIDS AND LIPOPROTEINS OF THE POLAR BEAR
    KADUCE, TL
    SPECTOR, AA
    FOLK, GE
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1981, 69 (03): : 541 - 545
  • [35] PLASMA-LIPIDS AND LIPOPROTEINS AND ESSENTIAL-HYPERTENSION
    FLESCH, M
    SACHINIDIS, A
    KO, YD
    KRAFT, K
    VETTER, H
    CLINICAL INVESTIGATOR, 1994, 72 (12): : 944 - 950
  • [36] EFFECTS OF EXERCISE ON PLASMA-LIPIDS AND LIPOPROTEINS OF WOMEN
    KRUMMEL, D
    ETHERTON, TD
    PETERSON, S
    KRISETHERTON, PM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1993, 204 (02): : 123 - 137
  • [37] PLASMA-LIPIDS AND LIPOPROTEINS IN LIVER-DISEASE
    MCINTYRE, N
    GUT, 1978, 19 (06) : 526 - 530
  • [38] EFFECTS OF INDORAMIN AND METOPROLOL ON PLASMA-LIPIDS AND LIPOPROTEINS
    MARTINEZ, TLR
    AURIEMO, CRC
    MACHADO, AMO
    CUNHA, MA
    FERES, MC
    MALDJIAN, S
    WORTSMAN, A
    DELBONI, FOH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 : S76 - S79
  • [40] STUDIES ON DIET AND PLASMA-LIPIDS IN NAPLES
    FARINARO, E
    RUBBA, P
    POSTIGLIONE, A
    RICCARDI, G
    MANCINI, M
    PROGRESS IN BIOCHEMICAL PHARMACOLOGY, 1982, 19 : 123 - 128